Dorsa Jahangiri
1 
, Mohammadreza Ardalan
2* , Muhammed Mubarak
3 , Shahrzad Alimohammadi
4,5 , Hamid Reza Jahantigh
6,7 , Sanam Saeifar
8 1 Independent Researcher, 43185 Cardston Place Leesburg Virginia, 20176, USA
2 Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 JIK Department of Histopathology, Sindh Institute of Urology and Transplantation, Karachi, Pakistan
4 Doctoral School of Molecular Medicine, University of Debrecen, Debrecen, Hungary
5 Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
6 Interdisciplinary Department of Medicine - Section of Occupational Medicine, University of Bari, Bari, Italy
7 Animal Health and Zoonosis PhD Course, Department of Veterinary Medicine, University of Bari, Bari, Italy
8 Buchmann Institute for Molecular Life Sciences (BMLS), Cluster of Excellence Frankfurt Macromolecular Complexes (CEF-MC), Goethe University Frankfurt am Main, Frankfurt am Main, Germany
Implication for health policy/practice/research/medical education:
Methamphetamine abuse typically causes acute kidney injury mainly due to rhabdomyolysis, malignant hypertension and volume depletion and acute tubular necrosis. However, methamphetamine-induced crescentic glomerulonephritis (CresGN) has not been reported so far.
Please cite this paper as: Jahangiri D, Ardalan M, Mubarak M, Alimohammadi S, Jahantigh HR, Saeifar S. Crescentic glomerulonephritis in a man with a history of methamphetamine abuse; a possible cause for concern. J Nephropharmacol. 2023;12(1):e10508. DOI: 10.34172/ npj.2022.10508.